Merck KGaA Fertility Business And Mavenclad Held Back By COVID-19 But Recovery Signs

Candidate Anti-COVID Toll-like Receptor Inhibitor Starts Phase II

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.